🕵️ Charles River Laboratories International, Inc. ($CRL)
SEC insider & ownership activity, last 12 months · CIK 1100682 · every row links its SEC filing
Over the last 12 months insiders sold $17.1M against $4K of open-market buying. James C. Foster sold $16.9M through a 10b5-1 trading plan in 1 lots (Jun). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $4K (1 lots) · 2 sellers, $17.1M (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| James C. Foster | 0 | – | 1 | $16.9M | Jun 29, 2026 |
| Joseph W. Laplume | 1 | $4K | 3 | $252K | Mar 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.4% | 13G | Apr 29, 2026 | filing ↗ | |
| FMR LLC | 7.0% | 13G | May 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 7.0% | 13G | May 6, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.9% | 13G | Apr 17, 2025 | filing ↗ | |
| Wellington Management Company LLP | 5.7% | 13G | Nov 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| James C. Foster | $16.9M | Jun 29, 2026 | filing ↗ |
| Joseph Laplume | $61K | Aug 22, 2025 | filing ↗ |
| Joseph Laplume | $126K | Aug 18, 2025 | filing ↗ |
| Richard F. Wallman | $3.4M | Aug 18, 2025 | filing ↗ |
| Joseph Laplume | $60K | Aug 7, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing ↗ |
| Other events (8.01) | Nov 14, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 12, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 12, 2025 | filing ↗ |
| Earnings (2.02) | Aug 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2025 | filing ↗ |